Patents by Inventor Tani Lee

Tani Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for predicting response of triple-negative breast cancer to therapy
    Patent number: 10697967
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: June 30, 2020
    Assignee: Société des Produits Nestlé S.A.
    Inventors: Xinjun Liu, Phillip Kim, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • METHODS FOR PREDICTING RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER TO THERAPY
    Publication number: 20170227542
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: September 20, 2016
    Publication date: August 10, 2017
    Applicant: DiaTech Holdings, Inc.
    Inventors: Xinjun Liu, Phillip Kim, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy
    Patent number: 9726669
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: August 8, 2017
    Assignee: PIERIAN HOLDINGS, INC.
    Inventors: Phillip Kim, Xinjun Liu, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • Methods for predicting response of triple-negative breast cancer to therapy
    Patent number: 9488654
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Grant
    Filed: July 10, 2012
    Date of Patent: November 8, 2016
    Assignee: DIATECH HOLDINGS, INC.
    Inventors: Xinjun Liu, Phillip Kim, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • METHODS FOR PREDICTING RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER TO THERAPY
    Publication number: 20130012407
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: July 10, 2012
    Publication date: January 10, 2013
    Applicant: Nestec S.A.
    Inventors: Xinjun Liu, Phillip Kim, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY
    Publication number: 20110071042
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: August 10, 2010
    Publication date: March 24, 2011
    Applicant: Prometheus Laboratories Inc.
    Inventors: Phillip Kim, Xinjun Liu, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh